Skip header and navigation

15 records – page 1 of 1.

Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight

https://policybase.cma.ca/en/permalink/policy14125
Date
2019-Sep-03
Topics
Health care and patient safety
Population health/ health equity/ public health
{add= CMA response: HEALTH CANADA CONSULTATION ON POTENTIAL MARKET FOR CANNABIS
  1 document  

Health Canada consultation on Canadian drugs and substances strategy

https://policybase.cma.ca/en/permalink/policy14017
Date
2018-Dec-04
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
to the criminal law affecting cannabis must not promote normalization of its use and must be tied to a national
  1 document  

Bill C-45: The Cannabis Act

https://policybase.cma.ca/en/permalink/policy13861
Date
2018-Apr-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
{add= CMA Submission: Bill C-45: The Cannabis Act
  1 document  

CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy13918
Date
2018-Feb-15
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
  1 document  

Proposed approach to the regulation of cannabis

https://policybase.cma.ca/en/permalink/policy13838
Date
2018-Jan-19
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
{add= CMA submission: PROPOSED APPROACH TO THE REGULATION OF CANNABIS
  1 document  

Excise duty framework for cannabis products

https://policybase.cma.ca/en/permalink/policy13799
Date
2017-Dec-07
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
{add= CMA Submission: Excise Duty Framework for Cannabis
  1 document  

Bill C-45: The Cannabis Act

https://policybase.cma.ca/en/permalink/policy13723
Date
2017-Aug-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
{add= CMA Submission: Bill C-45: The Cannabis Act Submission to the House of Commons
  1 document  

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/en/permalink/policy13726
Date
2017-May-26
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J. & Room, R. (2017). Lower-Risk Cannabis
  1 document  

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy13641
Date
2017-Apr-07
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
to youth, such as soft drinks and cannabis, to be a positive step. A recent report published
  1 document  

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/en/permalink/policy11954
Date
2016-Aug-29
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Cannabis Use Guidelines for Canada g 27 should be discussed, particularly with teens, in an effort
  2 documents  

CMA statement authorizing marijuana for medical purposes (update 2015)

https://policybase.cma.ca/en/permalink/policy11514
Date
2015-Feb-28
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
and  the College of Family Physicians of Canada’s preliminary guidance Authorizing Dried Cannabis for Chronic
  1 document  

The Health risks and harms associated with the use of marijuana

https://policybase.cma.ca/en/permalink/policy11138
Date
2014-May-27
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
, or cannabis, is a Schedule II drug under the Canadian Controlled Drugs and Substances Act, and growing
  1 document  

Cannabis for Medical Purposes

https://policybase.cma.ca/en/permalink/policy10045
Date
2010-Dec-04
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
that credit is given to Canadian Medical Association. CMA POLICY Cannabis for Medical Purposes
  1 document  

CMA Letter to the Senate Committee on Legal and Constitutional Affairs regarding Bill C-2, An Act to amend the Criminal Code and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy9110
Date
2008-Feb-19
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
groups. Published reports indicate that the prevalence of driving under the influence of cannabis
  1 document  

A Public Health Perspective on Cannabis and Other Illegal Drugs : CMA Submission to the Special Senate Committee on Illegal Drugs

https://policybase.cma.ca/en/permalink/policy1968
Date
2002-Mar-11
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  2 documents  

15 records – page 1 of 1.